KYMR
Price
$64.86
Change
+$0.55 (+0.86%)
Updated
Nov 19, 01:48 PM (EDT)
Capitalization
4.63B
92 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$28.87
Change
-$0.04 (-0.14%)
Updated
Nov 19, 02:04 PM (EDT)
Capitalization
1.85B
120 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs VERA

Header iconKYMR vs VERA Comparison
Open Charts KYMR vs VERABanner chart's image
Kymera Therapeutics
Price$64.86
Change+$0.55 (+0.86%)
Volume$125
Capitalization4.63B
Vera Therapeutics
Price$28.87
Change-$0.04 (-0.14%)
Volume$200
Capitalization1.85B
KYMR vs VERA Comparison Chart in %
KYMR
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KYMR vs. VERA commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (KYMR: $64.38 vs. VERA: $28.87)
Brand notoriety: KYMR and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 48% vs. VERA: 97%
Market capitalization -- KYMR: $4.63B vs. VERA: $1.85B
KYMR [@Biotechnology] is valued at $4.63B. VERA’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 7 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • VERA’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +1.59% price change this week, while VERA (@Biotechnology) price change was -2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was -2.53%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

VERA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.63B) has a higher market cap than VERA($1.85B). KYMR YTD gains are higher at: 60.017 vs. VERA (-31.733). VERA has higher annual earnings (EBITDA): -210.52M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. VERA (557M). VERA has less debt than KYMR: VERA (77.6M) vs KYMR (85.7M). KYMR has higher revenues than VERA: KYMR (44.7M) vs VERA (0).
KYMRVERAKYMR / VERA
Capitalization4.63B1.85B251%
EBITDA-267.03M-210.52M127%
Gain YTD60.017-31.733-189%
P/E RatioN/AN/A-
Revenue44.7M0-
Total Cash665M557M119%
Total Debt85.7M77.6M110%
TECHNICAL ANALYSIS
Technical Analysis
KYMRVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 29 days ago
87%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDSX36.820.09
+0.25%
Artisan Small Cap Advisor
FSPSX60.27N/A
N/A
Fidelity International Index
RMDCX3.33N/A
N/A
Virtus Silvant Mid-Cap Growth C
BSGIX15.12N/A
N/A
Baird Small/Mid Cap Growth Institutional
TSRLX80.54N/A
N/A
Touchstone Large Cap Focused R6

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.43%
NRIX - KYMR
64%
Loosely correlated
-1.02%
VERA - KYMR
61%
Loosely correlated
-2.00%
IDYA - KYMR
54%
Loosely correlated
+1.08%
RGNX - KYMR
54%
Loosely correlated
+0.94%
NUVL - KYMR
54%
Loosely correlated
-3.48%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-2.00%
KYMR - VERA
60%
Loosely correlated
+0.43%
LYRA - VERA
53%
Loosely correlated
-2.41%
VYGR - VERA
42%
Loosely correlated
+4.26%
CRNX - VERA
41%
Loosely correlated
-1.17%
BNTX - VERA
41%
Loosely correlated
-0.14%
More